Global Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Region: COVID-19 Impact and Growth Opportunity

Report ID: 51296 | Published Date: Sep 2024 | No. of Page: 207 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	10
1.2 Research Methodology	13
1.2.1 Overview of Market Research Methodology	13
1.2.2 Market Assumption	14
1.2.3 Secondary Data	14
1.2.4 Primary Data	14
1.2.5 Data Filtration and Model Design	15
1.2.6 Market Size/Share Estimation	16
1.2.7 Research Limitations	17
1.3 Executive Summary	18
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	23
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Global Market by Vaccine Type	41
3.1 Market Overview by Vaccine Type	41
3.2 Live/Attenuated Vaccines	43
3.3 Inactivated Vaccines	44
3.4 Subunit Vaccines	45
3.5 Toxoid Vaccines	46
3.6 Conjugate Vaccines	47
3.7 Recombinant Vector Vaccines	48
3.8 Other Vaccines	49
4 Segmentation of Global Market by Disease	50
4.1 Market Overview by Disease	50
4.2 Vaccines for Pneumococcal Disease	52
4.3 Vaccines for Poliovirus	53
4.4 Vaccines for Hepatitis	54
4.5 Vaccines for Influenza	55
4.6 Vaccines for Measles, Mumps, and Rubella (MMR)	56
4.7 Vaccines for Varicella	57
4.8 Vaccines for Human Papilloma Virus	58
4.9 Vaccines for COVID-19	59
4.10 Vaccines for Other Diseases	62
5 Segmentation of Global Market by Administration	63
5.1 Market Overview by Administration	63
5.2 Intramuscular Route	65
5.3 Subcutaneous Route	66
5.4 Oral Route	67
5.5 Intravenous Injection	68
5.6 Other Administration Routes	69
6 Segmentation of Global Market by Patient	70
6.1 Market Overview by Patient	70
6.2 Pediatric Vaccines	72
6.3 Adult Vaccines	74
7 Segmentation of Global Market by Region	76
7.1 Geographic Market Overview 2020-2026	76
7.2 North America Market 2020-2026 by Country	80
7.2.1 Overview of North America Market	80
7.2.2 U.S.	83
7.2.3 Canada	88
7.2.4 Mexico	91
7.3 European Market 2020-2026 by Country	94
7.3.1 Overview of European Market	94
7.3.2 UK	97
7.3.3 France	100
7.3.4 Germany	103
7.3.5 Spain	106
7.3.6 Italy	109
7.3.7 Russia	112
7.3.8 Rest of European Market	115
7.4 Asia-Pacific Market 2020-2026 by Country	117
7.4.1 Overview of Asia-Pacific Market	117
7.4.2 China	120
7.4.3 Japan	123
7.4.4 India	127
7.4.5 Australia	130
7.4.6 South Korea	133
7.4.7 Rest of APAC Region	136
7.5 South America Market 2020-2026 by Country	138
7.5.1 Argentina	141
7.5.2 Brazil	144
7.5.3 Colombia	147
7.5.4 Rest of South America Market	150
7.6 MEA Market 2020-2026 by Country	151
7.6.1 UAE	154
7.6.2 Saudi Arabia	157
7.6.3 Egypt	160
7.6.4 Other National Markets	163
8 Competitive Landscape	164
8.1 Overview of Key Vendors	164
8.2 New Product Launch, Partnership, Investment, and M&A	167
8.3 Company Profiles	168
AstraZeneca plc	168
Bavarian Nordic A/S	171
China National Biotec Group Company Ltd.	174
CSL Ltd.	176
Daiichi Sankyo Co. Ltd	178
Emergent BioSolutions Inc.	180
GlaxoSmithKline plc	182
Johnson & Johnson	186
Merck & Co.	188
Moderna Inc.	190
Novavax, Inc.	191
Pfizer Inc.	193
Sanofi SA	197
Takeda Pharmaceutical Co. Ltd.	199
9 Investing in Global Market: Risk Assessment and Management	201
9.1 Risk Evaluation of Global Market	201
9.2 Critical Success Factors (CSFs)	204
Related Reports and Products	207
Table 1.  Snapshot of Global Preventive Vaccines Market in Balanced Perspective, 2020-2026	19
Table 2. Growth Rate of World GDP, 2020-2022	24
Table 3.  Main Product Trends and Market Opportunities in Global Preventive Vaccines Market	33
Table 4. Global Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	41
Table 5. Global Preventive Vaccines Market by Disease, 2016-2026, $ mn	50
Table 6. COVID-19 Vaccines Authorized for Emergency Use or Approved for Full Use, as of April 2021	60
Table 7. Global Preventive Vaccines Market by Administration, 2016-2026, $ mn	63
Table 8. Global Preventive Vaccines Market by Patient, 2016-2026, $ mn	70
Table 9. Global Preventive Vaccines Market: Pediatric Vaccines by Disease, 2016-2026, $ mn	73
Table 10. Global Preventive Vaccines Market: Adult Vaccines by Disease, 2016-2026, $ mn	75
Table 11. Global Preventive Vaccines Market by Region, 2016-2026, $ mn	77
Table 12.  Leading National Preventive Vaccines Market, 2020 and 2026, $ mn	79
Table 13. North America Preventive Vaccines Market by Country, 2016-2026, $ mn	82
Table 14. U.S. Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	85
Table 15. U.S. Preventive Vaccines Market by Disease, 2016-2026, $ mn	85
Table 16. U.S. Preventive Vaccines Market by Administration, 2016-2026, $ mn	86
Table 17. Canada Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	89
Table 18. Canada Preventive Vaccines Market by Disease, 2016-2026, $ mn	89
Table 19. Canada Preventive Vaccines Market by Administration, 2016-2026, $ mn	90
Table 20. Mexico Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	92
Table 21. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn	92
Table 22. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn	93
Table 23. Europe Preventive Vaccines Market by Country, 2016-2026, $ mn	96
Table 24. UK Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	98
Table 25. UK Preventive Vaccines Market by Disease, 2016-2026, $ mn	98
Table 26. UK Preventive Vaccines Market by Administration, 2016-2026, $ mn	99
Table 27. France Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	101
Table 28. France Preventive Vaccines Market by Disease, 2016-2026, $ mn	101
Table 29. France Preventive Vaccines Market by Administration, 2016-2026, $ mn	102
Table 30. Germany Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	104
Table 31. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn	104
Table 32. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn	105
Table 33. Spain Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	107
Table 34. Spain Preventive Vaccines Market by Disease, 2016-2026, $ mn	107
Table 35. Spain Preventive Vaccines Market by Administration, 2016-2026, $ mn	108
Table 36. Italy Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	110
Table 37. Italy Preventive Vaccines Market by Disease, 2016-2026, $ mn	110
Table 38. Italy Preventive Vaccines Market by Administration, 2016-2026, $ mn	111
Table 39. Russia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	113
Table 40. Germany Preventive Vaccines Market by Disease, 2016-2026, $ mn	113
Table 41. Germany Preventive Vaccines Market by Administration, 2016-2026, $ mn	114
Table 42. Preventive Vaccines Market in Rest of Europe by Country, 2016-2026, $ mn	116
Table 43. APAC Preventive Vaccines Market by Country, 2016-2026, $ mn	119
Table 44. China Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	121
Table 45. China Preventive Vaccines Market by Disease, 2016-2026, $ mn	121
Table 46. China Preventive Vaccines Market by Administration, 2016-2026, $ mn	122
Table 47. Japan Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	125
Table 48. Japan Preventive Vaccines Market by Disease, 2016-2026, $ mn	125
Table 49. Japan Preventive Vaccines Market by Administration, 2016-2026, $ mn	126
Table 50. India Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	128
Table 51. India Preventive Vaccines Market by Disease, 2016-2026, $ mn	128
Table 52. India Preventive Vaccines Market by C Administration, 2016-2026, $ mn	129
Table 53. Australia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	131
Table 54. Australia Preventive Vaccines Market by Disease, 2016-2026, $ mn	131
Table 55. Australia Preventive Vaccines Market by Administration, 2016-2026, $ mn	132
Table 56. South Korea Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	134
Table 57. South Korea Preventive Vaccines Market by Disease, 2016-2026, $ mn	134
Table 58. South Korea Preventive Vaccines Market by Administration, 2016-2026, $ mn	135
Table 59. Preventive Vaccines Market in Rest of APAC by Country, 2016-2026, $ mn	137
Table 60. South America Preventive Vaccines Market by Country, 2016-2026, $ mn	140
Table 61. Argentina Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	142
Table 62. Argentina Preventive Vaccines Market by Disease, 2016-2026, $ mn	142
Table 63. Argentina Preventive Vaccines Market by Administration, 2016-2026, $ mn	143
Table 64. Brazil Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	145
Table 65. Brazil Preventive Vaccines Market by Disease, 2016-2026, $ mn	145
Table 66. Brazil Preventive Vaccines Market by Administration, 2016-2026, $ mn	146
Table 67. Colombia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	148
Table 68. Mexico Preventive Vaccines Market by Disease, 2016-2026, $ mn	148
Table 69. Mexico Preventive Vaccines Market by Administration, 2016-2026, $ mn	149
Table 70. MEA Preventive Vaccines Market by Country, 2016-2026, $ mn	153
Table 71. UAE Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	155
Table 72. UAE Preventive Vaccines Market by Disease, 2016-2026, $ mn	155
Table 73. UAE Preventive Vaccines Market by Administration, 2016-2026, $ mn	156
Table 74. Saudi Arabia Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	158
Table 75. Saudi Arabia Preventive Vaccines Market by Disease, 2016-2026, $ mn	158
Table 76. Saudi Arabia Preventive Vaccines Market by Administration, 2016-2026, $ mn	159
Table 77. Egypt Preventive Vaccines Market by Vaccine Type, 2016-2026, $ mn	161
Table 78. Egypt Preventive Vaccines Market by Disease, 2016-2026, $ mn	161
Table 79. Egypt Preventive Vaccines Market by Administration, 2016-2026, $ mn	162
Table 80. AstraZeneca plc: Company Snapshot	168
Table 81. AstraZeneca plc: Revenue, 2018-2020, $ bn	169
Table 82. Bavarian Nordic A/S: Company Snapshot	171
Table 83. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020	172
Table 84. China National Biotec Group Company Ltd.: Company Snapshot	174
Table 85. CSL Ltd.: Company Snapshot	176
Table 86. Daiichi Sankyo Co. Ltd.: Company Snapshot	178
Table 87. Emergent BioSolutions Inc.: Company Snapshot	180
Table 88. GlaxoSmithKline: Company Snapshot	182
Table 89. GlaxoSmithKline: Business Segmentation	183
Table 90. GlaxoSmithKline: Product Portfolio	184
Table 91. GlaxoSmithKline: Revenue, 2018-2020, $ bn	185
Table 92. GlaxoSmithKline: Recent Developments	185
Table 93. Johnson & Johnson: Company Snapshot	186
Table 94. Johnson & Johnson: Business Segments	187
Table 95. Merck & Co., Inc.: Company Snapshot	188
Table 96. Merck & Co., Inc.: Business Segmentation	188
Table 97. Merck & Co., Inc.: Revenue, 2018-2020, $ bn	189
Table 98. Moderna Inc.: Company Snapshot	190
Table 99. Novavax, Inc.: Company Snapshot	191
Table 100. Pfizer Inc.: Company Snapshot	193
Table 101. Pfizer Inc.: Business Segmentation	194
Table 102. Pfizer Inc.: Product Portfolio	195
Table 103. Pfizer Inc.: Revenue, 2018-2020, $ bn	196
Table 104. Pfizer Inc.: Recent Developments	196
Table 105. Sanofi: Company Snapshot	197
Table 106. Sanofi: Business Segmentation	197
Table 107. Sanofi: Revenue, 2018-2020, $ bn	198
Table 108. Takeda Pharmaceutical Co. Ltd.: Company Snapshot	199
Table 109.  Risk Evaluation for Investing in Global Market, 2020-2026	202
Table 110. Critical Success Factors and Key Takeaways	205
Figure 1. Research Method Flow Chart	13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2026	18
Figure 4. Global Preventive Vaccines Market, 2016-2026, $ mn	21
Figure 5. Development Stages of Preventive Vaccines	22
Figure 6. Impact of COVID-19 on Business	25
Figure 7. Primary Drivers and Impact Factors of Global Preventive Vaccines Market	27
Figure 8. Primary Restraints and Impact Factors of Global Preventive Vaccines Market	30
Figure 9. Investment Opportunity Analysis	34
Figure 10. Porter’s Fiver Forces Analysis of Global Preventive Vaccines Market	37
Figure 11. Breakdown of Global Preventive Vaccines Market by Vaccine Type, 2020-2026, % of Revenue	42
Figure 12. Contribution to Global 2021-2026 Cumulative Revenue by Vaccine Type, Value ($ mn) and Share (%)	42
Figure 13. Global Preventive Vaccines Market: Live/Attenuated Vaccines, 2016-2026, $ mn	43
Figure 14. Global Preventive Vaccines Market: Inactivated Vaccines, 2016-2026, $ mn	44
Figure 15. Global Preventive Vaccines Market: Subunit Vaccines, 2016-2026, $ mn	45
Figure 16. Global Preventive Vaccines Market: Toxoid Vaccines, 2016-2026, $ mn	46
Figure 17. Global Preventive Vaccines Market: Conjugate Vaccines, 2016-2026, $ mn	47
Figure 18. Global Preventive Vaccines Market: Recombinant Vector Vaccines, 2016-2026, $ mn	48
Figure 19. Global Preventive Vaccines Market: Other Vaccines, 2016-2026, $ mn	49
Figure 20. Breakdown of Global Preventive Vaccines Market by Disease, 2020-2026, % of Revenue	51
Figure 21. Contribution to Global 2021-2026 Cumulative Revenue by Disease, Value ($ mn) and Share (%)	51
Figure 22. Global Preventive Vaccines Market: Vaccines for Pneumococcal Disease, 2016-2026, $ mn	52
Figure 23. Global Preventive Vaccines Market: Vaccines for Poliovirus, 2016-2026, $ mn	53
Figure 24. Global Preventive Vaccines Market: Vaccines for Hepatitis, 2016-2026, $ mn	54
Figure 25. Global Preventive Vaccines Market: Vaccines for Influenza, 2016-2026, $ mn	55
Figure 26. Global Preventive Vaccines Market: Vaccines for Measles, Mumps, and Rubella (MMR), 2016-2026, $ mn	56
Figure 27. Global Preventive Vaccines Market: Vaccines for Varicella, 2016-2026, $ mn	57
Figure 28. Global Preventive Vaccines Market: Vaccines for Human Papilloma Virus, 2016-2026, $ mn	58
Figure 29. Global Preventive Vaccines Market: Vaccines for COVID-19, 2016-2026, $ mn	59
Figure 30. Global Preventive Vaccines Market: Vaccines for Other Diseases, 2016-2026, $ mn	62
Figure 31. Breakdown of Global Preventive Vaccines Market by Administration, 2020-2026, % of Revenue	64
Figure 32. Contribution to Global 2021-2026 Cumulative Revenue by Administration, Value ($ mn) and Share (%)	64
Figure 33. Global Preventive Vaccines Market: Intramuscular Route, 2016-2026, $ mn	65
Figure 34. Global Preventive Vaccines Market: Subcutaneous Route, 2016-2026, $ mn	66
Figure 35. Global Preventive Vaccines Market: Oral Route, 2016-2026, $ mn	67
Figure 36. Global Preventive Vaccines Market: Intravenous Injection, 2016-2026, $ mn	68
Figure 37. Global Preventive Vaccines Market: Other Administration Routes, 2016-2026, $ mn	69
Figure 38. Breakdown of Global Preventive Vaccines Market by Patient, 2020-2026, % of Revenue	70
Figure 39. Contribution to Global 2021-2026 Cumulative Revenue by Patient, Value ($ mn) and Share (%)	71
Figure 40. Global Preventive Vaccines Market: Pediatric Vaccines, 2016-2026, $ mn	72
Figure 41. Global Preventive Vaccines Market: Adult Vaccines, 2016-2026, $ mn	74
Figure 42.  Global Market Snapshot by Region	76
Figure 43.  Geographic Spread of Worldwide Preventive Vaccines Market, 2020-2026, % of Revenue	77
Figure 44. Contribution to Global 2021-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%)	78
Figure 45.  North American Preventive Vaccines Market, 2016-2026, $ mn	81
Figure 46. Breakdown of North America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	81
Figure 47. Contribution to North America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	82
Figure 48. U.S. Preventive Vaccines Market, 2016-2026, $ mn	84
Figure 49. Canada Preventive Vaccines Market, 2016-2026, $ mn	88
Figure 50.  Preventive Vaccines Market in Mexico, 2016-2026, $ mn	91
Figure 51.  European Preventive Vaccines Market, 2016-2026, $ mn	95
Figure 52. Breakdown of European Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	95
Figure 53. Contribution to Europe 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	96
Figure 54.  Preventive Vaccines Market in UK, 2016-2026, $ mn	97
Figure 55.  Preventive Vaccines Market in France, 2016-2026, $ mn	100
Figure 56.  Preventive Vaccines Market in Germany, 2016-2026, $ mn	103
Figure 57.  Preventive Vaccines Market in Spain, 2016-2026, $ mn	106
Figure 58.  Preventive Vaccines Market in Italy, 2016-2026, $ mn	109
Figure 59.  Preventive Vaccines Market in Russia, 2016-2026, $ mn	112
Figure 60.  Preventive Vaccines Market in Rest of Europe, 2016-2026, $ mn	115
Figure 61. Asia-Pacific Preventive Vaccines Market, 2016-2026, $ mn	118
Figure 62. Breakdown of APAC Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	118
Figure 63. Contribution to APAC 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	119
Figure 64.  Preventive Vaccines Market in China, 2016-2026, $ mn	120
Figure 65.  Preventive Vaccines Market in Japan, 2016-2026, $ mn	124
Figure 66.  Preventive Vaccines Market in India, 2016-2026, $ mn	127
Figure 67.  Preventive Vaccines Market in Australia, 2016-2026, $ mn	130
Figure 68.  Preventive Vaccines Market in South Korea, 2016-2026, $ mn	133
Figure 69.  Preventive Vaccines Market in Rest of APAC, 2016-2026, $ mn	136
Figure 70. South America Preventive Vaccines Market, 2016-2026, $ mn	139
Figure 71. Breakdown of South America Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	139
Figure 72. Contribution to South America 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	140
Figure 73.  Preventive Vaccines Market in Argentina, 2016-2026, $ mn	141
Figure 74.  Preventive Vaccines Market in Brazil, 2016-2026, $ mn	144
Figure 75.  Preventive Vaccines Market in Colombia, 2016-2026, $ mn	147
Figure 76.  Preventive Vaccines Market in Rest of South America, 2016-2026, $ mn	150
Figure 77. Preventive Vaccines Market in Middle East and Africa (MEA), 2016-2026, $ mn	152
Figure 78. Breakdown of MEA Preventive Vaccines Market by Country, 2020 and 2026, % of Revenue	152
Figure 79. Contribution to MEA 2021-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	153
Figure 80.  Preventive Vaccines Market in UAE, 2016-2026, $ mn	154
Figure 81.  Preventive Vaccines Market in Saudi Arabia, 2016-2026, $ mn	157
Figure 82.  Preventive Vaccines Market in Egypt, 2016-2026, $ mn	160
Figure 83. Growth Stage of Global Preventive Vaccines Industry over the Forecast Period	164
Figure 84.  Top Products of AstraZeneca Based on Revenue from 2016 to 2019 (in million U.S. dollars)	169
Companies Included in Reports:
Key Players (this may not be a complete list and extra companies can be added upon request): 
AstraZeneca plc
Bavarian Nordic A/S
China National Biotec Group Company Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Moderna Inc.
Novavax, Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.	
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions
Global Preventive Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Preventive Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Preventive Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports